Liaoning Quarkman Product Testing Co.,ltd

The China Pharmaceutical Capital Large Instrument Public Technical Service Platform is located in the National Liaoning Biomedical Science and Technology Industrial Base R&D Center. It is an important part of the China Pharmaceutical Capital R&D Center. It covers a total area of ​​2848m2 and has existing instrument assets of more than 30 million yuan, including 600MHz NMR. Resonance instrument, liquid chromatography mass spectrometer, gas chromatography mass spectrometer, liquid chromatograph, gas chromatograph, infrared spectrometer, flow cytometer, fluorescence quantitative PCR instrument, ultra-high speed centrifuge, fluorescence microscope Waiting for more than 50 large-scale analysis and detection instruments and 10,000-level purified cell rooms. The China Pharmaceutical Capital Public Service Platform team has a rich background in chemical and biological drug research and development, and has extensive experience in effectively handling research projects in various complex systems. At present, the platform has cooperated with large international pharmaceutical companies to develop 2 new Class I drugs, develop 5 generic drug projects, and synthesize thousands of new compounds.